SVB Leerink Upgrades Satsuma Pharmaceuticals (STSA) to Outperform
Tweet Send to a Friend
SVB Leerink analyst Marc Goodman upgraded Satsuma Pharmaceuticals (NASDAQ: STSA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
